T-cell exhaustion due to BiTE therapy in multiple myeloma: mitigating infectious risks through treatment-free intervals
Multiple Myeloma (MM), a highly treatable but thus far incurable hematologic malignancy, has required continuous monitoring and treatment throughout a patient’s lifetime. Newer classes of therapies, such as chimeric antigen receptor (CAR) T-cell therap…